Risankizumab is currently FDA-approved under the brand name Skyrizi for the treatment of moderate to severe plaque psoriasis.
Investigators of the retrospective cohort study evaluated adherence to guideline-supported eradication testing for Helicobacter pylori infection.
Investigators analyzed the surgical risk for ulcerative colitis and Crohn disease in contemporary, population-based inception cohorts vs 20th century cohorts.
Available as a sulfate-based tablet, Sutab provides an alternative to liquid-based colonoscopy preparations.
In response to the rising incidence of CRC in patients younger than 50 years, the USPSTF proposes CRC screening at 45 years as the new clinical standard.
Developmental and behavioral functioning often associated with children diagnosed with ASD may be linked to a nonverbal manifestation of gastrointestinal symptoms.
An analysis of 3 large prospective cohorts examined the association between dietary patterns with high inflammatory potential and increased risks for Crohn disease and ulcerative colitis.
A case of COVID-19 transmission in a high-rise apartment complex in China demonstrates the probable transmission of SARS-CoV-2 through fecal aerosols.
Danish investigators conducted a cohort study to assess the impact of low-dose aspirin on lower gastrointestinal bleeding, colorectal bleeding, and colorectal polyps.
Acute pancreatitis may be a gastrointestinal manifestation of COVID-19, according to researchers from the University of Arkansas for Medical Sciences.